Tags: Chemical Compound, Chemical Substance.

Coluracetam (BCI-540) is a nootropic drug of the racetam family. Coluracetam (formerly known as MKC-231) was initially developed and tested by the Mitsubishi Tanabe Pharma Corporation for Alzheimer’s disease. After the drug failed to reach endpoints in its clinical trials it was in-licensed by BrainCells Inc for investigations into major depression disorder (MDD) after being awarded a Qualifying Therapeutic Discovery Program Grant by the state of California.

Coluracetam.svg
FDA UNII code
V6FL6O5GR7
IUPAC name
N-(23-dimethyl-5678- tetrahydrofuro[23-b] quinolin-4-yl)-2- (2-oxopyrrolidin-1-yl)acetamide

Loading...

This page contains content from the copyrighted Wikipedia article "Coluracetam"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.